Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Glatiramer Acetate clinical trials
7 selected ClinicalTrials.gov records carrying the official matched intervention Glatiramer Acetate (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
7 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 25 selected PubMed records and 11 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT00451451
PeptideScanner retained ClinicalTrials.gov record NCT00451451 at 2026-11-16T17:42:50.457Z. Its registry update date was 2015-01-26, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- January 26, 2015
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00856635
PeptideScanner retained ClinicalTrials.gov record NCT00856635 at 2026-11-16T17:42:50.457Z. Its registry update date was 2018-02-06, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- February 6, 2018
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00947752
PeptideScanner retained ClinicalTrials.gov record NCT00947752 at 2026-11-16T17:42:50.457Z. Its registry update date was 2017-03-14, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- March 14, 2017
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Glatiramer acetate · 2021-12-09
ClinicalTrials.gov record NCT02499900
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2018-11-05
ClinicalTrials.gov record NCT02153723
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2018-06-08
ClinicalTrials.gov record NCT01569451
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2018-02-06
ClinicalTrials.gov record NCT00856635
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2017-03-14
ClinicalTrials.gov record NCT00947752
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2016-01-14
ClinicalTrials.gov record NCT01874145
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2015-01-26
ClinicalTrials.gov record NCT00451451
Completed at the retained observation.
Open attributed record →